Lokesh Kalekar —BIO-PROTOCOL

Home About Us

Archive

Abhijit Kale Deciduous Therapeutics
10 protocols

Alexandros Alexandratos National and Kapodistrian University of Athens
39 protocols

Anita Umesh Illumina
4 protocols

Anna Köhler Georg August Universität Göttingen
1 protocol

Editor

Lokesh Kalekar

Research scientist, eGenesis Inc

Research focus

Immunology
Immunology, stem cells, autoimmunity, cancer immunology

Reviewer merit
Editor merit

Education

PhD, University of Minnesota, Twin Cities, 2016

Lab information

Mike Rosenblum lab, UCSF

Publications

https://www.linkedin.com/in/lokesh-kalekar-14288310b/

11 Protocols reviewed

Skin Transplantation and Lymphoid Organ Analysis in Mice

Authors: Julie Ruer-Laventie, Rajesh Jayachandran, Mathias Schmaler, Simona W. Rossi and Jean Pieters, date: 02/20/2020, view: 1588, Q&A: 0

Skin transplantation in mice is an important procedure to evaluate immune responses generated against heterologous grafts, especially given its highly immunogenic nature. In fact, skin is one of the most challenging organs in terms of allograft ...

More >

Protein- and Sequencing-based Massively Parallel Single-cell Approaches to Gene Expression Profiling

Authors: Xuhuai Ji, Igor Goncharov, Miao Zhao, Molly Miranda and Holden T. Maecker, date: 02/05/2019, view: 4482, Q&A: 0

Understanding cellular diversity and dynamics in immune cells are critical for elucidating mechanisms of diagnosis, response to therapeutics, and patient prognosis. Our goal is to apply a technically simple approach for gene expression cytometry ...

More >

More protocols >

5 Protocols edited

Methodology for in vitro Assessment of Human T Cell Activation and Blockade

Authors: Joseph R. Podojil, Igal Ifergan, Ming-Yi Chiang, Joshua J. Meeks and Stephen D. Miller, date: 06/05/2020, view: 1229, Q&A: 0

Methods to test both the functionality and mechanism of action for human recombinant proteins and antibodies in vitro have been limited by multiple factors. To test the functionality of a recombinant protein or antibody, the receptor, the ...

More >

Direct Reprogramming of Mouse Embryonic Fibroblasts to Conventional Type 1 Dendritic Cells by Enforced Expression of Transcription Factors

Authors: Fábio F. Rosa, Cristiana F. Pires, Olga Zimmermannova and Carlos-Filipe Pereira, date: 05/20/2020, view: 1530, Q&A: 0

Ectopic expression of transcription factor combinations has been recently demonstrated to reprogram differentiated somatic cells towards the dendritic cell (DC) lineage without reversion to a multipotent state. DCs have the ability to induce potent ...

More >

More protocols >